AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,623,000 | +59.3% | 974,719 | -0.3% | 0.06% | +41.0% |
| Q3 2019 | $20,478,000 | +33.3% | 977,927 | +32.6% | 0.04% | +34.5% |
| Q2 2019 | $15,357,000 | +21.2% | 737,626 | +30.1% | 0.03% | +16.0% |
| Q1 2019 | $12,671,000 | -11.3% | 566,934 | -5.1% | 0.02% | -26.5% |
| Q4 2018 | $14,291,000 | +8.6% | 597,459 | +23.9% | 0.03% | +30.8% |
| Q3 2018 | $13,154,000 | +0.4% | 482,196 | -1.0% | 0.03% | 0.0% |
| Q2 2018 | $13,103,000 | -9.2% | 487,272 | +7.5% | 0.03% | -16.1% |
| Q1 2018 | $14,429,000 | – | 453,320 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
| Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
| Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
| Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
| SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
| Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
| Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
| EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |